Why knee cartilage cannot heal on its own

A knee can carry significant cartilage damage and feel, for a time, entirely ordinary. That is not reassurance — it is a consequence of how cartilage is built.

Unlike skin or bone, articular cartilage has no internal repair crew. It is avascular (no blood vessels), aneural (no nerve fibres), and alymphatic (no lymph channels). When bone fractures, bleeding summons repair cells within hours. When cartilage is damaged, nothing arrives — because there is no circulatory route by which repair cells could reach the site. The chondrocytes that maintain cartilage tissue sit locked inside a dense extracellular matrix; they cannot migrate to an injury, so no healing response is ever triggered.

The absence of nerve fibres compounds the problem. Pain is ordinarily the body's early-warning system, prompting a person to rest, seek advice, and limit further harm. Cartilage carries none of those fibres, so early-stage damage produces no warning signal. Patients can sustain lesions that are clinically meaningful — and progressively enlarging — while the knee feels broadly manageable. By the time symptoms such as swelling, clicking, or a catching sensation do emerge, the underlying damage may already be well advanced.

This biology is why cartilage damage is treated differently from most orthopaedic injuries, and why early assessment matters even when a knee is not yet causing significant trouble.

What the damage does if left alone

The progression that follows an unrepaired focal defect is not dramatic — it is incremental, and that is part of what makes it clinically serious.

Each time the joint loads, the unprotected defect transfers mechanical stress to its edges. A 2019 porcine study found measurable loss of sulfated glycosaminoglycans (sGAGs) — the structural proteoglycans that give cartilage its load-bearing stiffness — in the tissue immediately surrounding a defect under continued loading. As those edge tissues weaken, the lesion boundary shifts outward. Damage that begins as a small focal problem can, over time, become a larger and structurally compromised zone.

Defect size matters at every stage of this process. Injuries exceeding approximately 1 cm carry a recognised threshold beyond which the risk of progressive worsening and eventual osteoarthritis increases substantially. At the patellofemoral joint specifically, high-grade lesions — ICRS grade III (extending more than half the cartilage depth) or grade IV (full thickness, into subchondral bone) — carry a documented risk of progressing to patellofemoral arthritis if left unmanaged.

How quickly this unfolds is not fixed. Defect size, anatomical location, loading pattern, and individual biomechanics all influence the pace. It is worth being explicit: long-term randomised data on untreated defects of specified sizes do not exist in humans, because withholding treatment for controlled observation is not ethically permissible. Progression timelines are therefore clinician-estimated rather than population-averaged.

For high-demand athletes, the trajectory carries particular weight. Sports-medicine literature has explicitly described progressive untreated cartilage loss as a career-ending course — not as an outlier outcome, but as the documented direction of travel without intervention.

Who is actually a candidate for repair

Not every damaged knee is a cartilage repair candidate. The single most important distinction — between a focal defect and diffuse osteoarthritis — determines whether repair is clinically appropriate or whether a different pathway is needed. Repair techniques are designed to restore isolated areas of damage surrounded by structurally sound cartilage; they are not suited to joints where the articular surface has deteriorated broadly and unevenly.

Several factors combine to establish suitability. Defect area is a primary gate: lesion size, together with the grade already noted, shapes which technique is appropriate and whether surrounding tissue can support repair. Patient profile matters equally — age, activity level, BMI, and limb alignment all influence whether a repair is likely to hold. Alignment is particularly consequential: a systematic review of 2,267 patients found reoperation rates of 47.4% after standalone cartilage repair, falling to 17.3% when concomitant osteotomy corrected an underlying malalignment fault. Younger, active patients with a focal defect and otherwise healthy joint mechanics have the strongest published evidence base for repair over early joint replacement.

Conservative management — physiotherapy, load modification, and analgesic support — is ordinarily the appropriate first response for lower-grade or recently diagnosed lesions. Repair moves up the priority order when those measures fail, when symptoms become functionally limiting, or when imaging identifies a higher-grade lesion carrying meaningful risk of further expansion. A specialist assessment is needed to weigh these factors individually; no single threshold triggers repair automatically.

Repair techniques and how defect size shapes the choice

Technique choice is not arbitrary — it follows a rough ladder that rises with defect size, though no single threshold is absolute.

Smaller defects (up to approximately 2 cm²)

Microfracture — drilling small holes through the subchondral bone to recruit marrow cells — has historically been the first-line option for contained defects below 2 cm². Its limitation is well-established: the repair tissue produced is fibrocartilage rather than true hyaline cartilage, structurally weaker and less durable under load. A 3.6-year follow-up study found 36% of microfracture repairs remained incompletely healed, and repeated drilling damages the subchondral bone plate, which can narrow future repair options. It is no longer regarded as the preferred modern choice, even at the smaller end of the size range. AMIC (autologous matrix-induced chondrogenesis) addresses the core weakness by adding a scaffold layer over the marrow stimulation site, giving recruited progenitor cells a structured environment — a single-stage step up without the complexity of cell culture.

Mid-range defects (roughly 2–4 cm²)

OATS or mosaicplasty transfers cylindrical osteochondral plugs from a lower-load area of the joint to the defect site. The technique suits defects in the 1–4 cm² range and delivers genuine hyaline cartilage, though donor-site morbidity is a real consideration. For this size band, cell-based procedures — ACI and MACI — also become viable; both are two-stage, resource-intensive, and carry the strongest mid-term evidence for defects up to 10 cm².

Larger and post-traumatic defects (above ~4 cm²)

The SUMMIT trial demonstrated meaningfully better KOOS pain and function scores for MACI over microfracture at both 2 and 5 years in lesions of 3 cm² or greater. Where defects are very large or the result of significant trauma and autograft tissue is insufficient, osteochondral allograft (OCA) — using cadaveric donor tissue in a single-stage procedure — provides an option that neither autograft nor cell-based approaches can match for scale.

Outpatient injectable scaffold

For suitable focal defects, ultrasound-guided injectable collagen scaffold treatments represent a non-surgical pathway: a scaffold is delivered to the defect under imaging guidance in an outpatient setting, where it recruits the patient's own progenitor cells to support repair — a process termed matrix-induced chondrogenesis. ChondroFiller is the CE-marked device used in this category within current MSK practice.

Defect size shapes these options, but it does not determine outcome alone. As the next section covers, limb alignment can override size-based selection entirely.

Why limb alignment can determine whether repair succeeds

Those reoperation figures carry a practical implication that is easy to overlook at the decision stage: a technically well-executed cartilage repair can still fail if the underlying mechanical environment is wrong. Malalignment — a varus or valgus deviation in the leg — concentrates load disproportionately on one compartment. When the repaired tissue sits in that compartment, it absorbs more force with every step than it was designed to bear, and the repair breaks down regardless of the technique used or how skilled the surgeon was.

Two procedures address this directly. High tibial osteotomy (HTO) shifts load away from a damaged medial compartment; distal femoral osteotomy (DFO) does the equivalent for the lateral side. Both work by correcting the mechanical axis of the leg rather than the cartilage itself. They can be performed alongside a cartilage repair in the same operating session or staged as a preliminary procedure, depending on the clinical picture.

For patients planning a cartilage repair, the practical question is whether alignment has been formally assessed as part of the work-up. If it has not been raised, it is worth asking — because addressing a malalignment fault at the point of repair, rather than after a reoperation, is where the evidence most clearly indicates a difference in outcome.

Getting the right specialist assessment

A specialist assessment for focal cartilage damage should establish three things: the defect grade and surface area (confirmed on MRI or weightbearing imaging), whether limb alignment has been formally evaluated, and which treatment pathway — surgical, scaffold-based, or conservative — is matched to the clinical picture. Search MSK lists knee cartilage specialists across the UK who provide this kind of structured evaluation; filtering by region and specialty will identify clinicians offering the relevant repair pathways near you.

Arriving at that consultation with a few direct questions — What ICRS grade is the defect? Has alignment been assessed? What technique fits my defect size and activity level? — is reasonable preparation. A patient who leaves with clear answers to those three points is in a meaningfully better position to act on the evidence in this article before a lesion that began silently continues to expand.